These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86. Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c. Cloete R; Kapp E; Joubert J; Christoffels A; Malan SF PLoS One; 2018; 13(11):e0207605. PubMed ID: 30475855 [TBL] [Abstract][Full Text] [Related]
87. Mce-associated protein Rv0177 alters the cell wall structure of Mycobacterium smegmatis and promotes macrophage apoptosis via regulating the cytokines. Yan S; Zhen J; Li Y; Zhang C; Stojkoska A; Lambert N; Li Q; Li P; Xie J Int Immunopharmacol; 2019 Jan; 66():205-214. PubMed ID: 30472521 [TBL] [Abstract][Full Text] [Related]
88. Yang J; Zhang L; Qiao W; Luo Y MedComm (2020); 2023 Oct; 4(5):e353. PubMed ID: 37674971 [TBL] [Abstract][Full Text] [Related]
89. Evaluating the Impact of the Tyr158 p Davoodi S; Daryaee F; Iuliano JN; Tolentino Collado J; He Y; Pollard AC; Gil AA; Aramini JM; Tonge PJ Biochemistry; 2023 Jun; 62(12):1943-1952. PubMed ID: 37270808 [TBL] [Abstract][Full Text] [Related]
90. The pathogenic mechanism of Mycobacterium tuberculosis: implication for new drug development. Yan W; Zheng Y; Dou C; Zhang G; Arnaout T; Cheng W Mol Biomed; 2022 Dec; 3(1):48. PubMed ID: 36547804 [TBL] [Abstract][Full Text] [Related]
91. How Bhagwat A; Deshpande A; Parish T Front Cell Infect Microbiol; 2022; 12():974101. PubMed ID: 36159638 [TBL] [Abstract][Full Text] [Related]
92. The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry. Messner K; Vuong B; Tranmer GK Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337063 [TBL] [Abstract][Full Text] [Related]
93. Designing of a Chimeric Vaccine Using EIS (Rv2416c) Protein Against Mycobacterium tuberculosis H37Rv: an Immunoinformatics Approach. Logesh R; Lavanya V; Jamal S; Ahmed N Appl Biochem Biotechnol; 2022 Jan; 194(1):187-214. PubMed ID: 34817805 [TBL] [Abstract][Full Text] [Related]
94. A Novel Benzoxaborole Is Active against Escherichia coli and Binds to FabI. Mandal S; Parish T Antimicrob Agents Chemother; 2021 Aug; 65(9):e0262220. PubMed ID: 34152809 [TBL] [Abstract][Full Text] [Related]